Gene interactions and pathways from curated databases and text-mining

◀ Back to NOTCH1

NCSTN — NOTCH1

Pathways - manually collected, often from reviews:

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

Text-mined interactions from Literome

Mumm et al., Mol Cell 2000 : Gamma-secretase-like proteolysis at site 3 ( S3 ), within the transmembrane domain, releases the Notch intracellular domain ( NICD ) and activates CSL mediated Notch signaling
López-Schier et al., Dev Cell 2002 : Here we show that Drosophila Nicastrin is required for Notch signaling, and acts specifically at the S3 cleavage step
Li et al., J Biol Chem 2003 : These data demonstrate that Nicastrin is essential for the gamma-secretase cleavage of APP and Notch in mammalian cells and that Nicastrin has both positive and negative functions in the regulation of gamma-secretase activity
Curry et al., Oncogene 2005 (Sarcoma, Kaposi) : Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi 's sarcoma tumor cells
Koyanagi et al., Circ Res 2007 : Gamma-secretase dependent Notch activation is required for cardiac gene expression in human cells and induces the expression of noncanonical Wnt proteins, which may act in a paracrine manner to further amplify cardiac differentiation
Real et al., Nat Med 2009 (Precursor T-Cell Lymphoblastic Leukemia-Lymphoma) : Gamma-secretase inhibitors (GSIs) block the activation of the oncogenic protein Notch homolog-1 (NOTCH1) in T cell acute lymphoblastic leukemia ( T-ALL )
Pui et al., Cancer Cell 2009 (Precursor T-Cell Lymphoblastic Leukemia-Lymphoma) : Gamma-secretase inhibitors block the activation of NOTCH1 but have limited activity against T cell acute lymphoblastic leukemia ( T-ALL ) and cause severe gastrointestinal toxicity
Shimoyama et al., Arterioscler Thromb Vasc Biol 2010 (Diabetes Mellitus, Experimental...) : Gamma secretase inhibitor, an inhibitor of Notch signaling, partially inhibited the enhanced expression of p21 induced by CCN3
Li et al., Neurol Sci 2012 (Brain Ischemia) : Gamma-secretase inhibitor, N- [ N- ( 3,5-difluorophenacetyl ) -1-alanyl ] -S-phenylglycine t-butyl ester ( DAPT ) suppresses the activation of Notch 1 signaling, which is recognized as the cell fate signaling and may participate in inflammatory processes together with NF-?B pathway that contributes to the brain damage after stroke